Rocklatan® Evaluation

NCT05283395 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

136

Enrollment

INDUSTRY

Sponsor class

Conditions

Glaucoma

Interventions

DRUG: Netarsudil 0.02%/latanoprost 0.005% fixed dose combination ophthalmic solution

Sponsor

Aerie Pharmaceuticals